Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
58,643,980
-
Number of holders
-
182
-
Total 13F shares, excl. options
-
60,668,045
-
Shares change
-
+4,077,181
-
Total reported value, excl. options
-
$3,025,896,532
-
Value change
-
+$157,762,312
-
Put/Call ratio
-
80%
-
Number of buys
-
94
-
Number of sells
-
-94
-
Price
-
$49.88
Significant Holders of AGIOS PHARMACEUTICALS, INC. - Common Stock (AGIO) as of Q2 2019
236 filings reported holding AGIO - AGIOS PHARMACEUTICALS, INC. - Common Stock as of Q2 2019.
AGIOS PHARMACEUTICALS, INC. - Common Stock (AGIO) has 182 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 60,668,045 shares
.
Largest 10 shareholders include FMR LLC (8,806,700 shares), WELLINGTON MANAGEMENT GROUP LLP (6,806,240 shares), VANGUARD GROUP INC (4,638,769 shares), BlackRock Inc. (4,362,184 shares), Capital International Investors (3,258,526 shares), Bellevue Group AG (3,128,134 shares), PRICE T ROWE ASSOCIATES INC /MD/ (2,737,600 shares), FIRST TRUST ADVISORS LP (1,790,126 shares), STATE STREET CORP (1,747,115 shares), and GOLDMAN SACHS GROUP INC (1,525,446 shares).
This table shows the top 182 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.